Earlham Institute
- Company typePrivate
- Founded2009
- HeadquartersNorwich, United Kingdom
- Headcount101–250
- GTM typeB2B
- OfferingServices
Earlham Institute firmographics
Firmographics- Name
- Earlham Institute
- Legal name
- Earlham Institute
- Website
- https://earlham.ac.uk
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Earlham Institute industry classification
Industry- Product category
- Genomics Research Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Transcriptomics & Gene Expression Profiling Services (HLAGANAE)
- akta.pro secondary industry
- Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)
Keywords
Where Earlham Institute is headquartered
LocationHeadquarters
- HQ city
- Norwich
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Earlham Institute business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations
Revenue model
- BBSRC Strategic Funding: Core funding from Biotechnology and Biological Sciences Research Council (BBSRC) as one of eight strategically funded institutes. EI receives approximately £6.45M in BBSRC strategic funding (2015/16 figure mentioned) to operate National Capability for genomics and bioinformatics.
- Contract Research Services: Collaborative R&D projects with industry through consultancy and contract research arrangements. The Business Development and Impact team facilitates partnerships and commercializes research outputs.
- Technology Platform Services: Fee-for-service access to sequencing, bioinformatics, cloud computing, and training services. BBSRC-funded researchers may receive services free or at cost; commercial customers receive services at negotiated rates.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Hybrid | Multi-year contract | Academic/BBSRC-funded researchers |
| Subscription | Annual | Industrial/Commercial customers |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels6 records
Earlham Institute product offering
Product offeringCore offering
Earlham Institute is a research institute providing genomics and computational biology services through technology platforms including high-performance DNA sequencing, single-cell and spatial analysis, laboratory automation via the Earlham Biofoundry, and cloud-based bioinformatics infrastructure. It serves academic researchers, industry partners, and government agencies with contract research, collaborative R&D, fee-for-service technology access, and specialist training programmes, supported by open-source software tools and an Open and FAIR Data policy.
Differentiator
Problem solved
Functional benefit
Products and services
- High-Performance Sequencing Platform
Quantifiable outcome
- Identified tiger DNA 200 metres from zoo enclosures and completed world's first national survey of UK terrestrial biodiversity using airborne DNA techniques
- +1 more outcomes
Companies that use Earlham Institute
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Earlham Institute technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Earlham Institute partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- Natural History Museum LondoncoreJoint venture spin-out Agnos Biosciences™ launched to commercialize AirSeq™ technology for rapid airborne pathogen detection. This is the first venture in the Museum's history. The technology enables detection of thousands of species with applications in environmental monitoring, agriculture, food safety, and biosecurity.
- ELIXIRcoreEarlham Institute hosts the ELIXIR-UK Node, coordinating bioinformatics data, tools, standards and training in the UK for Europe and beyond. Ariadna Miquel-Clopés serves as ELIXIR-UK Node Coordinator.
- CyVersecoreCyVerse UK cloud computing platform is hosted at Earlham Institute, providing bioinformatics services, tools, compute resources and system administration to UK-based researchers. EI provides dedicated infrastructure, staff, and expertise.
- Designing Future Wheat ProgrammecoreBBSRC-funded flagship cross-institute programme bringing together biologists, breeders, and informaticians from eight research institutes and universities. EI provides genomics data generation, analysis, and computational infrastructure including Grassroots data management platform.
- John Innes CentrecoreCollaborative research partner at Norwich Research Park. Joint work on spatial imaging techniques for wheat yield improvement and other agricultural genomics projects.
- Quadram InstitutecoreCollaborative research partner at Norwich Research Park. Joint work on autophagy research, gut microbiome studies, and network medicine.
- Institute of Food ResearchcoreNorwich Research Park partner collaborating on research including network medicine and signaling pathways.
- University of East AngliacoreNorwich Research Park partner and academic institution. Joint programmes including PhD training and collaborative research projects.
- London Universities Purchasing Consortium (LUPC)minorNon-profit professional buying organization that is part of UK University Purchasing Consortia. LUPC is a leader in promoting respect for human rights in public supply chains and supports ethical procurement practices. EI maintains membership for procurement activities.
- Norwich Bioscience Institutes (NBI)corePartnership of bioscience research organizations sharing facilities, expertise, and resources at Norwich Research Park. Includes shared sustainability initiatives like Green Impact scheme.
- Agnos BiosciencescoreJoint venture spin-out company (with Natural History Museum) to commercialize AirSeq™ technology for tracking pathogens and diseases. EI maintains scientific partnership while Agnos Biosciences deploys the technology as an end-to-end service.
Scale indicators5 records
Recent moves8 records
Expansion highlights6 records
Earlham Institute competitors and assessment
Company assessmentDirect peers
- European Bioinformatics Institute (EMBL-EBI): Pan-European bioinformatics data infrastructure provider hosting open data, tools, and training services; runs the ELIXIR Hub. Directly comparable to Earlham's ELIXIR-UK Node and CyVerse UK cloud platforms.
- The Roslin Institute: Scotland-based BBSRC institute delivering livestock genetics, genomics, and bioinformatics R&D; comparable public-funding model and livestock/animal genomics services overlap.
- John Innes Centre: Norwich Research Park neighbour and BBSRC-strategically funded institute with overlapping programmes in wheat genomics, plant biology, and computational biology. Direct co-located peer inside the same research park ecosystem.
- Wellcome Sanger Institute: UK-based genomics research institute delivering high-throughput sequencing, single-cell, and computational biology services to academic and industry collaborators. Most directly comparable to Earlham Institute given overlapping public funding, genomics platforms, and translational mission.
- Quadram Institute: Norwich Research Park bioscience institute focused on gut microbiome, food, and health research, collaborating with Earlham on autophagy and microbiome studies. Direct co-located research peer.
- Wellcome Centre for Human Genetics: Oxford-based genomics research centre combining large-scale sequencing, statistical genetics, and structural biology services for academic and clinical users. Comparable genomics-services and translational offering.
Broad incumbents
- Broad Institute: Much larger US-based genomics and biomedical research organisation offering sequencing, single-cell, and computational biology services to academic and industry users. Comparable platforms but operates at substantially larger scale and funding base.
- Novogene: Global commercial provider of NGS sequencing, single-cell, and bioinformatics services to academic and industry customers. Comparable service line-up but commercially scaled and global in footprint where Earlham is grant-funded and UK-focused.
- Eurofins Genomics: Worldwide commercial provider of genomic services, sequencing, and bioinformatics for academic, pharma, and agri customers; comparable sequencing and bioinformatics offering but at substantially larger global commercial scale.
Emerging players
- 10x Genomics: Provider of single-cell and spatial genomics instruments (Chromium, Visium, MERSCOPE — used at Earlham) and analysis software. Complementary technology vendor overlapping with EI's single-cell and spatial platform services.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Earlham Institute social profiles
Digital presenceEarlham Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
Earlham Institute leadership team
Management profileNumber of profiles
Profiles12 records
Earlham Institute subsidiaries and ownership
Company hierarchySubsidiaries2 records
Earlham Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Earlham Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Earlham Institute
What does Earlham Institute do?
Earlham Institute is a research institute providing genomics and computational biology services through technology platforms including high-performance DNA sequencing, single-cell and spatial analysis, laboratory automation via the Earlham Biofoundry, and cloud-based bioinformatics infrastructure. It serves academic researchers, industry partners, and government agencies with contract research, collaborative R&D, fee-for-service technology access, and specialist training programmes, supported by open-source software tools and an Open and FAIR Data policy.
Is Earlham Institute a public or private company?
Earlham Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Earlham Institute founded?
Earlham Institute was founded in 2009. It employs 101 to 250 people.
Where is Earlham Institute based?
Earlham Institute is headquartered in Norwich, United Kingdom, in the Europe region.
How does Earlham Institute make money?
Three revenue lines are on record. BBSRC Strategic Funding is the primary driver. The others are contract Research Services and technology Platform Services.
Who are Earlham Institute's main competitors?
Direct peers on record are European Bioinformatics Institute (EMBL-EBI), The Roslin Institute, John Innes Centre, Wellcome Sanger Institute, Quadram Institute and Wellcome Centre for Human Genetics. Broad incumbents are Broad Institute, Novogene and Eurofins Genomics. 10x Genomics is listed as an emerging player.
Does Earlham Institute have an API?
No public API is recorded for Earlham Institute.
What industry is Earlham Institute in?
Earlham Institute's product category is Genomics Research Services. Its primary akta.pro industry code is HLAGANAE, Transcriptomics & Gene Expression Profiling Services, with a secondary code of HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D). Its NAICS code is 54171 and its SIC code is 8731.